Longitudinal growth retardation in a prepuberal girl with chronic myeloid leukemia on long-term treatment with imatinib.
about
Endocrine side effects of broad-acting kinase inhibitors.The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation.How I treat childhood CML.Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment.Clinical review: kinase inhibitors: adverse effects related to the endocrine system.Pediatric chronic myeloid leukemia is a unique disease that requires a different approachMicro-osmotic pumps for continuous release of the tyrosine kinase inhibitor bosutinib in juvenile rats and its impact on bone growthPhiladelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options.Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia.Management of chronic myeloid leukemia in childhood.Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia.Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis.Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood.Impact of the type of the BCR-ABL fusion transcript on the molecular response in pediatric patients with chronic myeloid leukemia.Bone metabolism during long-term treatment with imatinib.Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.Adverse effects of imatinib in children with chronic myelogenous leukemia.Long-term follow-up of children with chronic myeloid leukemia after hematopoietic stem cell transplantation and tyrosine kinase inhibitor therapy.Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia.Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
P2860
Q34574985-E6284960-A1E5-48D1-8BB9-CABBC2A313ADQ35664347-4A382C56-D146-42A1-A5FF-F54868C8C4C4Q35802202-11CEC8CA-8E30-44C2-ABFA-3AD8DD1747FDQ36577661-90929747-E7D3-4039-92C7-5FAA06D9E2AFQ36736494-CE05A70D-6E47-473C-9640-41B961E2D685Q37025981-27835D1F-5D2F-40B5-A079-170AD4CB719AQ37366495-F0587B2B-DE32-487C-A18D-130D58CE7049Q37810967-36B02A3E-ED10-4B1F-86F9-EB7135350D57Q37989418-31355A89-2D9C-4C27-825E-944EF0C7DF39Q37991223-E042D4D7-79BB-4002-97B1-8DF94D0F059BQ38813874-C927B16D-720C-4711-855D-727B3475646CQ39484798-0B08AEE7-D056-489A-8CFC-96705E72EC08Q42769654-5D9FB81B-C1E0-4F05-8907-E489327F6C39Q42792947-31E4FDF2-4E7B-4998-A36B-DB6D4C90E9D5Q45720889-180EF502-D9DA-4C42-8651-F3894E310C88Q51072279-2DD654FC-B7D5-434D-9355-693233839AF3Q51562409-4BD8E43E-ABA2-45BB-9F25-90BCF2C4DEC1Q52893458-4CBEA4A1-48E4-4B38-8841-C79DB178B1B9Q54491280-D776809E-2DB7-45A3-89D7-10CA82E7A294Q54614929-6D046C0F-C353-458D-BACD-19681AF750DF
P2860
Longitudinal growth retardation in a prepuberal girl with chronic myeloid leukemia on long-term treatment with imatinib.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Longitudinal growth retardatio ...... -term treatment with imatinib.
@en
Longitudinal growth retardatio ...... -term treatment with imatinib.
@nl
type
label
Longitudinal growth retardatio ...... -term treatment with imatinib.
@en
Longitudinal growth retardatio ...... -term treatment with imatinib.
@nl
prefLabel
Longitudinal growth retardatio ...... -term treatment with imatinib.
@en
Longitudinal growth retardatio ...... -term treatment with imatinib.
@nl
P2093
P2860
P1433
P1476
Longitudinal growth retardatio ...... -term treatment with imatinib.
@en
P2093
Bernadette A S Jaeger
Hansjoerg Schmid
Judith Lohse
Meinolf Suttorp
P2860
P304
P356
10.3324/HAEMATOL.2009.008359
P577
2009-06-22T00:00:00Z